Paul Winner

Summary

Publications

  1. ncbi Diagnosing migraine in the pediatric population
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 10:363-9. 2006
  2. ncbi Efficacy, safety, and tolerability of oxcarbazepine monotherapy
    Walter Martinez
    Premiere Research Institute, West Palm Beach, FL, USA
    Epilepsy Behav 9:448-56. 2006
  3. ncbi Childhood periodic syndromes and migraine
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology, Nova Southeastern University, 4631 North Congress Avenue, Suite 200, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 9:197-201. 2005
  4. ncbi Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, Florida 33407, USA
    Clin Ther 28:1582-91. 2006
  5. ncbi Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine
    Paul Winner
    Palm Beach Headache Center, 4631 N Congress Ave, Suite 200, West Palm Beach, FL 33407, USA
    Mayo Clin Proc 82:61-8. 2007
  6. ncbi Epidemiology and diagnosis of migraine in children
    Paul Winner
    Palm Beach Headache Center, 4631 North Congress Avenue, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 11:375-82. 2007
  7. ncbi Pediatric headache
    Paul Winner
    Palm Beach Headache Center, Nova Southeastern University, West Palm Beach, Florida 33407, USA
    Curr Opin Neurol 21:316-22. 2008
  8. ncbi Classification of pediatric headache
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology Nova Southeastern University, 4631 N Congress Avenue, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 12:357-60. 2008
  9. ncbi Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, FL 33407, USA
    Headache 46:212-22. 2006
  10. ncbi Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute, 5205 Greenwood Avenue, Ste 200, West Palm Beach, FL 33407, USA
    Clin Ther 27:1785-94. 2005

Collaborators

Detail Information

Publications29

  1. ncbi Diagnosing migraine in the pediatric population
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 10:363-9. 2006
    ..This article reviews the practical diagnostic issues related to migraine in the pediatric population...
  2. ncbi Efficacy, safety, and tolerability of oxcarbazepine monotherapy
    Walter Martinez
    Premiere Research Institute, West Palm Beach, FL, USA
    Epilepsy Behav 9:448-56. 2006
    ....
  3. ncbi Childhood periodic syndromes and migraine
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology, Nova Southeastern University, 4631 North Congress Avenue, Suite 200, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 9:197-201. 2005
    ..In this article, the diagnostic issues related to childhood periodic syndromes and migraine in the IHS 2004 revisions are reviewed...
  4. ncbi Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, Florida 33407, USA
    Clin Ther 28:1582-91. 2006
    ..The aim of this study was to assess the efficacy and tolerability of sumatriptan injection in the treatment of morning migraine...
  5. ncbi Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine
    Paul Winner
    Palm Beach Headache Center, 4631 N Congress Ave, Suite 200, West Palm Beach, FL 33407, USA
    Mayo Clin Proc 82:61-8. 2007
    ..To evaluate the long-term safety and tolerability of sumatriptan-naproxen sodium for the treatment of moderate to severe acute migraines and to assess the safety of administration of an optional second dose...
  6. ncbi Epidemiology and diagnosis of migraine in children
    Paul Winner
    Palm Beach Headache Center, 4631 North Congress Avenue, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 11:375-82. 2007
    ..These criteria provide the scientific basis for the study of headache, including the determination of the incidence and prevalence of pediatric migraine...
  7. ncbi Pediatric headache
    Paul Winner
    Palm Beach Headache Center, Nova Southeastern University, West Palm Beach, Florida 33407, USA
    Curr Opin Neurol 21:316-22. 2008
    ..Recent studies have revealed the increasing incidence of migraine and chronic migraine in the pediatric population...
  8. ncbi Classification of pediatric headache
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology Nova Southeastern University, 4631 N Congress Avenue, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 12:357-60. 2008
    ..Further research in pediatric headaches is needed to help reveal additional pathophysiologic mechanisms and improve diagnostic criteria...
  9. ncbi Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, FL 33407, USA
    Headache 46:212-22. 2006
    ..CONCLUSIONS: This study suggests that sumatriptan may be beneficial to some adolescents and is generally well tolerated in the acute treatment of migraine in this population...
  10. ncbi Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute, 5205 Greenwood Avenue, Ste 200, West Palm Beach, FL 33407, USA
    Clin Ther 27:1785-94. 2005
    ..In clinical trials evaluating sumatriptan in the treatment of moderate or severe migraine pain, the 50- and 100-mg doses have been comparably effective and well tolerated...
  11. ncbi Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial
    Paul Winner
    Nova Southeastern University, Fort Lauderdale, FL 33407, USA
    Headache 47:511-8. 2007
    ..Eletriptan is a potent 5-HT(1B/1D) agonist with proven efficacy in the acute treatment of migraine in adults...
  12. ncbi Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, FL, USA
    Headache 46:1503-10. 2006
    ..CONCLUSIONS: This post hoc subset analysis suggests that topiramate 100 and 200 mg/day, and possibly 50 mg/day, administered prophylactically for 26 weeks may reduce migraine in adolescents...
  13. ncbi Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis
    Jeffrey L Seeburger
    Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
    Headache 52:57-67. 2012
    ..To assess efficacy and tolerability of rizatriptan orally disintegrating tablet (ODT) for treatment of acute migraine in patients using topiramate for migraine prophylaxis...
  14. ncbi Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study
    Paul Winner
    Palm Beach Headache Center at Premiere Research Institute, West Palm Beach, Fla, USA
    Headache 42:49-55. 2002
    ..365), and the weekend placebo response rate was similar to that seen in adults. CONCLUSIONS: Rizatriptan 5 mg was well tolerated and effective on some measures when used in adolescents for the treatment of a migraine attack...
  15. ncbi Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies
    Paul Winner
    Palm Beach Headache Center, West Palm Beach, Fla, USA
    Mayo Clin Proc 78:1214-22. 2003
    ..Because these studies were not powered to detect statistical differences between active doses, studies to investigate this finding are warranted...
  16. ncbi Chronic daily headache in pediatric practice
    Paul Winner
    Palm Beach Headache Center, 5205 Greenwood Avenue, Suite 200, West Palm Beach, FL 33407, USA
    Curr Opin Neurol 15:297-301. 2002
    ..The management of the expectations of both the patient and family are the key to a good outcome...
  17. ncbi Triptans for migraine management in adolescents
    Paul Winner
    Premier Research Institute, Palm Beach Headache Center, West Palm Beach, Florida 33407, USA
    Headache 42:675-9. 2002
    ..CONCLUSION: Study results suggest that the triptan class of antimigraine drugs may effectively alleviate migraine in adolescents. Future research should address placebo response and earlier treatment paradigms...
  18. ncbi Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial
    Paul Winner
    Palm Beach Headache Center/Palm Beach Neurology, West Palm Beach, FL 33407, USA
    Headache 45:1304-12. 2005
    ..Topiramate was well tolerated in this population. Further randomized studies would be required to definitively establish the efficacy of topiramate for pediatric migraine prevention...
  19. ncbi How do we diagnose migraine and childhood periodic syndromes?
    Paul Winner
    Palm Beach Headache Center, Premiere Research Institute, Palm Beach Neurology, Nova Southeastern University, West Palm Beach, FL 33407, USA
    Curr Pain Headache Rep 9:345-50. 2005
    ..In this article, the diagnostic issues related to migraine and childhood periodic syndromes in the IHS 2004 revisions are reviewed...
  20. ncbi The placebo responder rate in children and adolescents
    Donald W Lewis
    Division of Pediatric Neurology, Children's Hospital of The King's Daughters, Eastern Virginia Medical School, Norfolk, VA 23510, USA
    Headache 45:232-9. 2005
  21. ncbi The treatment of pediatric migraine
    Donald W Lewis
    Children s Hospital of the King s Daughters, Eastern Virginia Medical School, Norfolk, VA, USA
    Pediatr Ann 34:448-60. 2005
    ....
  22. ncbi Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg
    Ninan T Mathew
    Houston (Tex) Headache Clinic, TX 77004, USA
    Headache 43:214-22. 2003
    ..2% sumatriptan, 2.8% placebo). CONCLUSION: This trial confirmed that eletriptan 40 mg offers superior efficacy in treating migraine pain and associated symptoms and in restoring patient functioning when compared with sumatriptan 100 mg...
  23. ncbi Nasal delivery of antimigraine drugs: clinical rationale and evidence base
    Alan Rapoport
    New England Center for Headache, Stanford, CT 06092-1251, USA
    Headache 46:S192-201. 2006
    ..Each of these drugs has a unique pharmacokinetic and pharmacodynamic profile, which may support a clinical preference for one intranasal agent over another in treating patients with specific headache features...
  24. ncbi Use of the ICHD-II criteria in the diagnosis of pediatric migraine
    Andrew D Hershey
    Division of Neurology, Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA
    Headache 45:1288-97. 2005
    ..4%...
  25. ncbi Headaches
    Andrew D Hershey
    Division of Neurology, Cincinnati Children s Hospital Medical Center and Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45229 3039, USA
    Curr Opin Pediatr 19:663-9. 2007
    ..Recent advances in diagnosis, epidemiology, and treatment have improved the outcomes of children with headaches. This review summarizes some of these findings...
  26. ncbi Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraine
    Anthony W Fox
    EBD Group, Carlsbad, CA 92009, USA
    Headache 42:680-8. 2002
    ..Comparison of use of therapeutic gain (TG) and therapeutic ratio (TR) for relative assessments of selective 5HT(1B/1D) agonist efficacy in the acute treatment of migraine...
  27. ncbi Efficacy of zolmitriptan nasal spray in adolescent migraine
    Donald W Lewis
    Division of Pediatric Neurology, Children s Hospital of the King s Daughters, Eastern Virginia Medical School, Norfolk, VA 23510, USA
    Pediatrics 120:390-6. 2007
    ..The goal was to evaluate the efficacy and tolerability of zolmitriptan nasal spray in the treatment of adolescent migraine...
  28. ncbi Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies
    W Hester Visser
    Merck Research Laboratories, West Point, PA 19486, USA
    Headache 44:891-9. 2004
    ..Rizatriptan 5 mg was well tolerated in adolescents during short-term and long-term use...
  29. ncbi Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents
    A David Rothner
    Cleveland Clinic Foundation, Cleveland, OH, USA
    Headache 46:101-9. 2006
    ..Furthermore, accurate information regarding the timeliness of treatment and reporting of headache-related information by adolescents is difficult...